title: Infectious nontuberculous serpiginous choroiditis.
authors.affiliation: Ocular Immunology and Uveitis Unit, Institute of Applied Ophthalmobiology, University of Valladolid, Valladolid, Spain.
authors.forename: Alejandro
authors.initials: A
authors.lastname: Portero
authors.forename: Ester
authors.initials: E
authors.lastname: Careño
authors.forename: Luis A
authors.initials: LA
authors.lastname: Real
authors.forename: Sonia
authors.initials: S
authors.lastname: Villarón
authors.forename: José M
authors.initials: JM
authors.lastname: Herreras
mesh_terms: D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000907:Antibodies, Bacterial / Q000097:blood; D001372:Aza Compounds / Q000627:therapeutic use; D018416:Bartonella henselae / Q000276:immunology / Q000302:isolation & purification*; D002372:Cat-Scratch Disease / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D002833:Choroiditis / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D002939:Ciprofloxacin / Q000627:therapeutic use; D015818:Eye Infections, Bacterial / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D005451:Fluorescein Angiography; D024841:Fluoroquinolones; D005604:Francisella tularensis / Q000276:immunology / Q000302:isolation & purification*; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D008297:Male; D008875:Middle Aged; D000077266:Moxifloxacin; D011804:Quinolines / Q000627:therapeutic use; D014406:Tularemia / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D014786:Vision Disorders; D014792:Visual Acuity / Q000502:physiology
chemical_list: D000890:Anti-Infective Agents; D000907:Antibodies, Bacterial; D001372:Aza Compounds; D024841:Fluoroquinolones; D007074:Immunoglobulin G; D011804:Quinolines; D002939:Ciprofloxacin; D000077266:Moxifloxacin